{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:43:56Z","timestamp":1761745436011,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes &amp; Metabolic Syndrome: Clinical Research &amp; Reviews"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.dsx.2021.01.015","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T20:44:17Z","timestamp":1612557857000},"page":"407-413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["A guidance on diagnosis and management of hyperglycemia at COVID care facilities in India"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4345-717X","authenticated-orcid":false,"given":"Yashdeep","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alpesh","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suraj","family":"Kubihal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0625-9342","authenticated-orcid":false,"given":"Kiran Kumar","family":"Golla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikhil","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.dsx.2021.01.015_bib3","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1111\/dom.14124","article-title":"Prevalence of co-morbidities and their association with mortality in patients with COVID-19: a systematic review and meta-analysis","volume":"22","author":"Singh","year":"2020","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.dsx.2021.01.015_bib4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13098-020-00586-4","article-title":"Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: a meta-analysis","volume":"12","author":"e Almeida-Pititto","year":"2020","journal-title":"Diabetol Metab Syndrome"},{"issue":"10","key":"10.1016\/j.dsx.2021.01.015_bib5","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1007\/s00125-020-05209-1","article-title":"Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study","volume":"63","author":"Wang","year":"2020","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.dsx.2021.01.015_bib6","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.cmet.2020.04.021","article-title":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes","volume":"31","author":"Zhu","year":"2020","journal-title":"Cell Metabol"},{"issue":"1","key":"10.1016\/j.dsx.2021.01.015_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.dsx.2020.12.033","article-title":"Glycemic parameters in new-onset diabetes during COVID-19 pandemic are more severe than new-onset diabetes before the pandemic: NOD COVID India study","volume":"15","author":"Ghosh","year":"2020","journal-title":"Diabetes Metab Syndr"},{"issue":"5","key":"10.1016\/j.dsx.2021.01.015_bib9","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.dsx.2020.08.003","article-title":"Strict glycemic control is needed in times of COVID19 epidemic in India: a Call for action for all physicians","volume":"14","year":"2020","journal-title":"Diabetes Metab Syndr"},{"issue":"5","key":"10.1016\/j.dsx.2021.01.015_bib10","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.dsx.2020.05.039","article-title":"Proposed guidelines for screening of hyperglycemia in patients hospitalized with COVID-19 in low resource settings","volume":"14","author":"Goyal","year":"2020","journal-title":"Diabetes Metab Syndr"},{"issue":"4","key":"10.1016\/j.dsx.2021.01.015_bib11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.dsx.2020.04.004","article-title":"Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations","volume":"14","author":"Singh","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.dsx.2021.01.015_bib12","doi-asserted-by":"crossref","first-page":"154378","DOI":"10.1016\/j.metabol.2020.154378","article-title":"Obesity in patients with COVID-19: a systematic review and meta-analysis","volume":"113","author":"Huang","year":"2020","journal-title":"Metabolism"},{"issue":"9","key":"10.1016\/j.dsx.2021.01.015_bib13","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-8587(20)30238-2","article-title":"COVID-19 in people with diabetes: understanding the reasons for worse outcomes","volume":"8","author":"Apicella","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"10.1016\/j.dsx.2021.01.015_bib14","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.2337\/dbi20-0032","article-title":"COVID-19 and diabetes: a collision and collusion of two diseases","volume":"69","author":"Feldman","year":"2020","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.dsx.2021.01.015_bib15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.dsx.2020.12.026","article-title":"Non-insulin anti-diabetic agents in patients with type 2 diabetes and COVID-19: a Critical Appraisal of Literature","volume":"15","author":"Singh","year":"2020","journal-title":"Diabetes Metab Syndr"},{"issue":"6","key":"10.1016\/j.dsx.2021.01.015_bib16","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S2213-8587(20)30152-2","article-title":"Practical recommendations for the management of diabetes in patients with COVID-19","volume":"8","author":"Bornstein","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"10.1016\/j.dsx.2021.01.015_bib17","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1007\/s13300-020-00873-3","article-title":"Basal-bolus insulin regimen for hospitalised patients with COVID-19 and diabetes mellitus: a practical approach","volume":"11","author":"Attri","year":"2020","journal-title":"Diabetes Ther"},{"issue":"4","key":"10.1016\/j.dsx.2021.01.015_bib18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.dsx.2020.04.013","article-title":"Diabetes self-management amid COVID-19 pandemic","volume":"14","author":"Banerjee","year":"2020","journal-title":"Diabetes Metab Syndr"},{"issue":"6","key":"10.1016\/j.dsx.2021.01.015_bib19","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.dsx.2020.09.009","article-title":"Clinical considerations in patients with diabetes during times of COVID19: an update on lifestyle factors and antihyperglycemic drugs with focus on India","volume":"14","author":"Gupta","year":"2020","journal-title":"Diabetes Metab Syndr"},{"issue":"1","key":"10.1016\/j.dsx.2021.01.015_bib20","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s12020-020-02294-5","article-title":"COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology","volume":"68","author":"Puig-Domingo","year":"2020","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.dsx.2021.01.015_bib21","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.dsx.2020.05.050","article-title":"Managing common endocrine disorders amid COVID-19 pandemic","volume":"14","author":"Pal","year":"2020","journal-title":"Diabetes Metab Syndr"},{"issue":"4","key":"10.1016\/j.dsx.2021.01.015_bib22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.dsx.2020.04.001","article-title":"Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: guidelines for physicians","volume":"14","author":"Ghosh","year":"2020","journal-title":"Diabetes Metab Syndr"},{"issue":"5","key":"10.1016\/j.dsx.2021.01.015_bib23","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.dsx.2020.06.007","article-title":"Pitfalls in telemedicine consultations in the era of COVID 19 and how to avoid them","volume":"14","author":"Iyengar","year":"2020","journal-title":"Diabetes Metab Syndr"},{"issue":"1","key":"10.1016\/j.dsx.2021.01.015_bib24","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jc.2011-2098","article-title":"Management of hyperglycemia in hospitalized patients in non-critical care setting: an Endocrine Society clinical practice guideline","volume":"97","author":"Umpierrez","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.dsx.2021.01.015_bib25","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.dsx.2020.12.029","article-title":"High prevalence of diabetes and other comorbidities in hospitalized patients with COVID-19 in Delhi, India, and their association with outcomes","volume":"15","author":"Mithal","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.dsx.2021.01.015_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108374","article-title":"Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration","author":"Fadini","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.dsx.2021.01.015_bib27","doi-asserted-by":"crossref","DOI":"10.2337\/dc20-1380","article-title":"Hyperglycemia at hospital admission is associated with severity of the prognosis in patients hospitalized for COVID-19: the Pisa COVID-19 Study","author":"Coppelli","year":"2020","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.dsx.2021.01.015_bib28","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.dsx.2020.08.034","article-title":"At-admission hyperglycemia is consistently associated with poor prognosis and early intervention can improve outcomes in patients with COVID-19","volume":"14","author":"Singh","year":"2020","journal-title":"Diabetes Metab Syndr"},{"issue":"1","key":"10.1016\/j.dsx.2021.01.015_bib29","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14378","article-title":"Dexamethasone therapy in COVID-19 patients: implications and guidance for the management of blood glucose in people with and without diabetes","volume":"38","author":"Rayman","year":"2021","journal-title":"Diabet Med"},{"issue":"5","key":"10.1016\/j.dsx.2021.01.015_bib30","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.pcd.2020.07.013","article-title":"COVID-19 and steroid therapy: impact on diabetes","volume":"14","author":"Mittal","year":"2020","journal-title":"Prim Care Diabetes"},{"key":"10.1016\/j.dsx.2021.01.015_bib31","article-title":"Dexamethasone in hospitalized patients with covid-19 - preliminary report","author":"Horby","year":"2020","journal-title":"N\u00a0Engl J Med"}],"container-title":["Diabetes &amp; Metabolic Syndrome: Clinical Research &amp; Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402121000175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402121000175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:13:26Z","timestamp":1761729206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402121000175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1871402121000175"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2021.01.015","relation":{},"ISSN":["1871-4021"],"issn-type":[{"type":"print","value":"1871-4021"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A guidance on diagnosis and management of hyperglycemia at COVID care facilities in India","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2021.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd on behalf of Diabetes India.","name":"copyright","label":"Copyright"}]}}